CVRx CEO reports equity grants and tax share sale

CVRx, Inc. president and CEO Kevin Hykes reported both an equity award and a small tax-related sale.

Rhea-AI Filing Summary

CVRx, Inc. president and CEO Kevin Hykes reported both an equity award and a small tax-related sale. He received a grant of 238,000 stock options and 159,000 restricted shares, which vest over several years. To cover tax withholding from these awards, he sold 7,763 common shares at a weighted average price of $7.9027 per share in mandated sell-to-cover transactions. After these trades, he directly owned 284,237 common shares.

Insider Trade Summary

Net Seller: 7,763 shares

Net Sell 3 txns

Insider Hykes Kevin

Role PRES & CEO

Sold 7,763 shs ($61K)

Type	Security	Shares	Price	Value
Sale	Common Stock	7,763	$7.9027	$61K
Grant/Award	Stock Option (right to buy)	238,000	$0.00	$0.00
Grant/Award	Common Stock	159,000	$0.00	$0.00

Holdings After Transaction: Stock Option (right to buy) — 238,000 contracts (Direct); Common Stock — 284,237 shares (Direct)

Footnotes (4)

1. F1. Restricted stock units that vest as to 25% of the shares on each annual anniversary of the grant date.
2. F2. The sale was mandated by the issuer's award agreement to satisfy tax withholding obligations by a sell-to-cover transaction.
3. F3. Reflects the weighted average price of 7,763 shares of common stock of CVRx, Inc. sold by the reporting person in multiple transactions on March 2, 2026 with sale prices ranging from $7.90 to $8.00 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
4. F4. Vests as to 25% of the shares on February 27, 2027 and as to 1/48th of the shares each month thereafter.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did CVRX CEO Kevin Hykes report on this Form 4?

Kevin Hykes reported receiving large equity awards and a small share sale. He was granted 238,000 stock options and 159,000 restricted shares, and sold 7,763 common shares in a mandated tax sell-to-cover transaction tied to these grants.

How many CVRX shares did CEO Kevin Hykes sell and at what price?

Kevin Hykes sold 7,763 CVRX common shares. The weighted average sale price was $7.9027 per share, with individual sale prices ranging from $7.90 to $8.00 across multiple transactions executed on the same trading day.

Were Kevin Hykes’ CVRX share sales discretionary or for tax withholding?

The sales were for tax withholding. The Form 4 states the 7,763-share sale was mandated by the issuer’s award agreement to satisfy tax withholding obligations through a sell-to-cover transaction, rather than being an ordinary discretionary open-market sale.

What new equity awards did CVRX grant to CEO Kevin Hykes?

Kevin Hykes received a grant of 238,000 stock options and 159,000 shares of common stock. These equity awards provide long-term compensation, with vesting schedules that extend over multiple years according to the terms disclosed in the accompanying footnotes.

How do Kevin Hykes’ new restricted CVRX shares vest over time?

The restricted stock units vest in stages. Twenty-five percent of the shares vest on the first annual anniversary of the grant date, with the remaining shares vesting in equal annual installments on each subsequent anniversary, aligning incentives over a multi-year period.

What is the vesting schedule for Kevin Hykes’ new CVRX stock options?

The stock options vest gradually over several years. Twenty-five percent of the option shares vest on February 27, 2027, and the remaining shares vest in equal 1/48th monthly installments thereafter, creating a four-year vesting timeline from the initial cliff date.

How many CVRX shares did Kevin Hykes own after these transactions?

Following the reported transactions, Kevin Hykes directly held 284,237 shares of CVRX common stock. This figure reflects his ownership after the mandated 7,763-share sell-to-cover transaction associated with the equity awards granted around the same time.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 06:03 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hykes Kevin

(Last) (First) (Middle)

9201 WEST BROADWAY, # 650

(Street)

MINNEAPOLIS MN 55445

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CVRx, Inc. [ CVRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	PRES & CEO

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/27/2026		A		159,000(1)	A	$0	292,000	D
Common Stock	03/02/2026		S(2)		7,763	D	$7.9027(3)	284,237	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$8.16	02/27/2026		A		238,000		(4)	02/26/2036	Common Stock	238,000	$0	238,000	D

Explanation of Responses:

1. Restricted stock units that vest as to 25% of the shares on each annual anniversary of the grant date.

2. The sale was mandated by the issuer's award agreement to satisfy tax withholding obligations by a sell-to-cover transaction.

3. Reflects the weighted average price of 7,763 shares of common stock of CVRx, Inc. sold by the reporting person in multiple transactions on March 2, 2026 with sale prices ranging from $7.90 to $8.00 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

4. Vests as to 25% of the shares on February 27, 2027 and as to 1/48th of the shares each month thereafter.

	/s/ Amy C. Seidel, Attorney-in-Fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.